Self-funded groups will continue to have options if they wish to include these drugs in their benefit programs
Merck and Daiichi Sankyo will work closely with the FDA and the third-party manufacturer to address the feedback as quickly as possible, Ken Takeshita, global head of R&D at Daiichi Sankyo, said in a statement
Side effects, particularly gastrointestinal issues (62.6%), were the most frequently reported adverse events, consistent with both studie, which reported 65% and 63%, respectively [23, 27]
Learning to read probiotic labels to spot hidden fillers is one of the highest-leverage skills in supplement selection, and many people prefer filler-free probiotics without unnecessary additives
Geng Z, Nie X, Ling L, Li B, Liu P, Yuan L, et al